The Globe and Mail reports in its Tuesday, Jan. 23, edition that Scotia Capital analyst Konark Gupta is sticking with his "sector outperform" recommendation for MDA. The Globe's David Leeder writes in the Eye On Equities column that Mr. Gupta advanced his share target by $1.50 to $16. Analysts on average target the shares at $14.68. Mr. Gupta says in a note: "MDA is one of our top picks this year. Shares performed the best in our coverage universe in 2023 (up 80 per cent) but have recently underperformed since the market troughed on Oct. 27, 2023. We believe last year's outperformance was driven mainly by management's strong execution on growth and margin as well as the mega Telesat Lightspeed contract win (worth $2.1-billion). However, the stock still has room to recover to the 2021 IPO price of $14-sh. We are most attracted to MDA's significant double-digit growth momentum with relatively steady margins and potential for FCF inflection in 2025/2026 when capex normalizes. In addition, the company is well-positioned to win several more orders to further solidify an already robust backlog with an opportunity pipeline worth $17-billion (and counting)."